Alterations in Fatty Acid Metabolism Across Neuronal Subtypes in Schizophrenia: Development of a Diagnostic Model
-
By
-
Cui Zhao
-
Liang Zhang
-
Ping Yang
-
Liang Li
-
Weiqi Zeng
-
Weiqi Xie
-
April 21, 2026
-
Clinical Scorecard: Alterations in Fatty Acid Metabolism Across Neuronal Subtypes in Schizophrenia: Development of a Diagnostic Model
At a Glance
| Category | Detail |
|---|
| Condition | Schizophrenia (SCZ) |
| Key Mechanisms | Dysregulation of fatty acid metabolism in specific neuronal subtypes. |
| Target Population | Patients diagnosed with schizophrenia. |
| Care Setting | Clinical research and diagnostic evaluation. |
Key Highlights
- Identification of five key genes associated with SCZ pathogenesis: ACAA1, ACAT2, ACSS1, PSME1, S100A10.
- Development of a multi-gene diagnostic model with an AUC of 0.856 in the training cohort.
- Significant upregulation of specific neuronal cell subtypes in SCZ patients.
- Negative correlation of key genes with inflammatory markers.
- Validation of gene expression in an MK-801-induced mouse SCZ model.
Guideline-Based Recommendations
Diagnosis
- Utilize a multi-gene diagnostic model based on identified fatty acid metabolism-related genes.
Management
- Consider the role of fatty acid metabolism in therapeutic strategies for SCZ.
Monitoring & Follow-up
- Monitor gene expression levels of key fatty acid metabolism-related genes in SCZ patients.
Risks
- Assess the potential for inflammatory responses linked to dysregulated fatty acid metabolism.
Patient & Prescribing Data
Individuals diagnosed with schizophrenia, particularly those with metabolic disturbances.
Targeting fatty acid metabolism may offer new therapeutic avenues.
Clinical Best Practices
- Incorporate single-cell sequencing data to understand cellular heterogeneity in SCZ.
- Use diagnostic models to improve accuracy in SCZ diagnosis and prognosis.
References
